TY - JOUR
T1 - The evolving law of CRISPR interview with professor Jacob Sherkow of New York Law School
AU - Davies, Kevin
AU - Sherkow, Jacob
N1 - Publisher Copyright:
© Kevin Davies 2018; Published by Mary Ann Liebert, Inc.
PY - 2018/6
Y1 - 2018/6
N2 - Given the exciting applications of CRISPR in fields ranging from gene therapy to genetically modified foods, there has naturally been intense scrutiny of the ongoing dispute regarding the discovery and patenting of CRISPR gene editing technology. No one has covered this story more intensively or adeptly than Professor Jacob Sherkow, an academic law professor at New York Law School. In this interview conducted by Dr. Kevin Davies (Executive Editor, The CRISPR Journal), Professor Sherkow provides a brief accessible history of the ongoing CRISPR patent dispute, discussing the implications as well as other legal issues, impacting the world of biotechnology. (This is a lightly edited version of the conversation, which was held on March 20, 2018.).
AB - Given the exciting applications of CRISPR in fields ranging from gene therapy to genetically modified foods, there has naturally been intense scrutiny of the ongoing dispute regarding the discovery and patenting of CRISPR gene editing technology. No one has covered this story more intensively or adeptly than Professor Jacob Sherkow, an academic law professor at New York Law School. In this interview conducted by Dr. Kevin Davies (Executive Editor, The CRISPR Journal), Professor Sherkow provides a brief accessible history of the ongoing CRISPR patent dispute, discussing the implications as well as other legal issues, impacting the world of biotechnology. (This is a lightly edited version of the conversation, which was held on March 20, 2018.).
UR - http://www.scopus.com/inward/record.url?scp=85048801952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048801952&partnerID=8YFLogxK
U2 - 10.1089/blr.2018.29068.kd
DO - 10.1089/blr.2018.29068.kd
M3 - Review article
AN - SCOPUS:85048801952
SN - 0730-031X
VL - 37
SP - 126
EP - 130
JO - Biotechnology Law Report
JF - Biotechnology Law Report
IS - 3
ER -